Section Arrow
SLP.NASDAQ
- Simulations Plus
Quotes are at least 15-min delayed:2025/06/06 04:08 EDT
Last
 27.76
+0.21 (+0.76%)
Day High 
28.635 
Prev. Close
27.55 
1-M High
34.01 
Volume 
264.83K 
Bid
25.2
Ask
29.29
Day Low
27.39 
Open
27.64 
1-M Low
25.77 
Market Cap 
554.06M 
Currency USD 
P/E 76.53 
%Yield 0.22 
10-SMA 30.73 
20-SMA 30.74 
50-SMA 30.2 
52-W High 50.11 
52-W Low 23.01 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.36/1.11
Enterprise Value
554.59M
Balance Sheet
Book Value Per Share
9.43
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
70.01M
Operating Revenue Per Share
2.96
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HCTIHealthcare Triangle0.0066-0.0005-7.04%-- 
TEMTempus AI Inc.58.695-4.085-6.51%-- 
TDOCTeladoc Health6.93-0.19-2.67%-- 
TXG10x Genomics9.11-0.23-2.46%-- 
DOCSDoximity57.34+2.77+5.08%49.16PE
Quotes are at least 15-min delayed:2025/06/06 04:08 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.